Skip to main content

Table 3 eGFR (MDRD) and UACR category prevalence of CKD in T2DM a

From: Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging

GFR category, ml/min/1.73 m2(MDRD)

Albuminuria category, mg/g

< 30

30-300

> 300

Rowc

N

% (95% CI)

N

% (95% CI)

N

% (95% CI)

N

% (95% CI)

G1 ≥ 90

629b

22.9 (20.7-25.1)

239

7.4 (6.1-8.6)

46

1.2 (0.7-1.7)

914

31.4 (28.9-34.0)

G2 60-89

834b

32.1 (29.4-34.7)

305

9.8 (8.3-11.3)

97

2.7 (2.0-3.3)

1236

44.6 (41.7-47.5)

G3a 45-59

267

9.6 (8.2-11.0)

141

4.0 (3.0-4.9)

51

1.4 (0.8-1.9)

459

14.9 (13.2-16.6)

G3b 30-44

88

2.9 (2.2-3.7)

74

2.1 (1.5-2.6)

40

1.2 (0.7-1.7)

202

6.2 (5.1-7.2)

G4 15-29

15

0.4 (0.2-0.5)

32

1.2 (0.6-1.7)

35

1.0 (0.4-1.6)

82

2.5 (1.8-3.2)

G5 < 15

d

0.0 (0.0-0.0)

d

0.0 (0.0-0.0)

20

0.4 (0.1-0.6)

22

0.5 (0.1-0.7)

Column N, % (95% CI) c

1834

67.8 (65.7-70.0)

792

24.4 (22.3-26.4)

289

7.8 (6.5-9.1)

2915

100 (N/A)

  1. aAge adjusted to 2012 NHIS diabetes population.
  2. bDoes not meet CKD criteria based on eGFR or albuminuria.
  3. c Sum of rows and columns may deviate due to rounding.
  4. dCell frequency suppressed when count < 3 to avoid potential identifiability and imprecision of estimates.
Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us